Recent advancements in stem cell technology open a new door for patients suffering from diseases and disorders that have yet to be treated. Moreover, we discuss our own clinical trial experiences on targeted therapies using MSCs in a clinical setting, and we propose and discuss the MSC tissue origin concept and how MSC origin may contribute to the role of MSCs in downstream applications, with the ultimate objective of facilitating translational research in regenerative medicine into clinical app...
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Aug 06, 2022 |
| Journal | Signal Transduction and Targeted Therapy |
| Authors | Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, Anh Toan Ngo, Quyen T. Nguyen |
| DOI | 10.1038/s41392-022-01134-4 |
| Citations | 1,027 |
| Source | OpenAlex |